Chongqing Yukaifa (000514.SZ) issues a forecasted pre-tax loss, anticipating a net loss of 75 million to 125 million yuan in the fiscal year 2024.

20/01/2025

GMT Eight

Chongqing Yukaifa (000514.SZ) released its annual performance forecast for 2024, expecting a net loss attributable to shareholders of the listed company of 75 million to 125 million yuan for the full year, a shift from profit to loss year-on-year.

CHINA VANKE (02202): "21 Vanke 02" will pay interest on January 22nd.

SIPAI HEALTH (00314) spent 715,600 Hong Kong dollars on January 20th to buy back 149,400 shares.

Contact: contact@gmteight.com

Chongqing Yukaifa (000514.SZ) issues a forecasted pre-tax loss, anticipating a net loss of 75 million to 125 million yuan in the fiscal year 2024.

RECOMMEND

Guangdong New Grand Long Packing (002836.SZ) expects a net profit of 59-73 million yuan for the year 2024, an increase of 203.03% - 274.94% year-on-year.

Hubei Biocause Pharmaceutical (000627.SZ) announces a forecasted net loss of between 500 million and 750 million yuan for the fiscal year 2024.

Jointo Energy Investment (000600.SZ) has forecasted a net profit of approximately 520 million yuan for the year 2024, representing a year-on-year growth of 175.68%.